Currently, the prevalence of migraine among people aged 18-65 in China is as high as 9.3%, which means that one out of every ten people suffers from migraine. Migraine attacks are most common in women, especially in young women, and can be triggered by changes in female hormones around menstruation, pregnancy and childbirth. In addition, migraines can also occur in children, which may be related to current lifestyle habits and mental stress. Thus, migraine affects a wide range of people and has a high incidence, and scientific and effective treatment methods have become extremely urgent. As the third most populous province in China, Henan has a high proportion of migraine patients. Because the pathogenesis of migraine has not yet formed a unified doctrine, and there are differences in the vascular doctrine, neurological doctrine and trigeminal vascular doctrine in the medical field, a complete treatment system has not yet been formed in the research and treatment of migraine in Henan local hospitals, and most of them still stay at the level of treatment by drugs, acupuncture and Chinese physical therapy, resulting in many patients with intractable migraine not getting timely and effective treatment. As a result, many patients with intractable migraine cannot receive timely and effective treatment and suffer from the pain repeatedly. Currently, microvascular decompression has gained a good reputation in the field of treatment of intractable migraine. Microvascular decompression is a minimally invasive surgery with an incision of about 3-5 cm and a quick postoperative recovery; the surgery is performed under a microscope and is extremely safe. The surgery is based on the principle of vascular compression of nerves, isolating the blood vessels and nerves in the compressed segment and restoring their parallel running trajectories, with excellent results.